TLR9 and inflammatory bowel disease: To further understand the role of viral antigens in the pathogenesis of IBD, we sought to investigate the role of EBV viral particles, rather than the DNA, in exacerbating the severity of intestinal inflammation and disease outcome, and evaluate the therapeutic role of a TLR9 inhibitor in mitigating the severity of IBD in a mouse model.